Forward Pharma A/S FWP

Full chart Compare
Set alert

Price alert · FWP

All alert types
1.95 +1.95

Day range unavailable

52-week range unavailable

Market cap
13.83M
Shares out
7.09M
Forward P/E
-21.67
Beta
1.38

2Y -4.71 (-70.72%)

246Dec 21Mar 22May 22Aug 22Nov 221.95

Key statistics

Enterprise value
-49.49M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.22
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-2.29M
Total cash
65.28M
Total debt
2.94M
Return on equity
-0.83%
Short % of float
0.00%
50-day average
2.76
200-day average
4.01

Upgrades / downgrades

FWP analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2020JMP SecuritiesdownMarket OutperformMarket Perform
Nov 25, 2020JefferiesdownBuyHold
Nov 25, 2020JMP Securitiesmain—Market Outperform
Nov 25, 2020Leerink Swannmain—Outperform
Nov 25, 2020Jefferiesmain—Buy
Nov 25, 2020Leerink Swannmain—Outperform

About Forward Pharma A/S

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Sector
Healthcare
Industry
Biotechnology
Country
Denmark

News

Your note

Sign in to keep a note on FWP — it syncs with the Stock Master app.

Institution ownership

FWP institution ownership
Holder% heldSharesValueReported
BVF Inc.7.25%513,7911.00MSep 29, 2022
Morgan Stanley2.30%163,299318.43KSep 29, 2022
Mason Capital Management, LLC2.12%150,217292.92KSep 29, 2022
Acadian Asset Management. LLC0.87%61,468119.86KSep 29, 2022
Perigon Wealth Management, Llc0.26%18,12435.34KSep 29, 2022
UBS Group AG0.03%2,1574.21KSep 29, 2022

Fund ownership

FWP fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.07%4,7359.23KOct 30, 2022